Cognex Corporation (NASDAQ:CGNX) Receives Average Rating of “Moderate Buy” from Brokerages

Posted by Geri Gentry on Sep 8th, 2026

Cognex Corporation (NASDAQ:CGNX – Get Free Report) has received an average recommendation of “Moderate Buy” from the seventeen brokerages that are covering the stock, MarketBeat.com reports. Five investment analysts have rated the stock with a hold recommendation, ten have given a buy recommendation and two have assigned a strong buy recommendation to the company. The average 1 year price target among brokerages that have issued ratings on the stock in the last year is $75.6429.

A number of equities analysts have recently commented on CGNX shares. Wall Street Zen raised Cognex from a “hold” rating to a “buy” rating in a report on Saturday. Barclays reiterated an “overweight” rating and set a $80.00 price objective (up from $75.00) on shares of Cognex in a research note on Monday, August 10th. JPMorgan Chase & Co. raised Cognex from a “neutral” rating to an “overweight” rating and increased their price objective for the stock from $65.00 to $75.00 in a report on Tuesday, May 26th. Seaport Research Partners set a $75.00 target price on Cognex in a research note on Tuesday, May 26th. Finally, The Goldman Sachs Group reaffirmed a “buy” rating and set a $91.00 target price on shares of Cognex in a report on Friday, August 7th.

View Our Latest Report on CGNX

Cognex Stock Performance

CGNX stock opened at $62.25 on Tuesday. The company has a market capitalization of $10.47 billion, a price-to-earnings ratio of 60.44 and a beta of 1.49. Cognex has a fifty-two week low of $34.60 and a fifty-two week high of $72.88. The stock has a fifty day moving average of $63.82 and a 200-day moving average of $59.89.

Cognex (NASDAQ:CGNX – Get Free Report) last announced its quarterly earnings results on Wednesday, August 5th. The scientific and technical instruments company reported $0.45 EPS for the quarter, beating analysts’ consensus estimates of $0.42 by $0.03. Cognex had a net margin of 16.05% and a return on equity of 13.50%. The company had revenue of $291.26 million for the quarter, compared to analysts’ expectations of $292.10 million. During the same period in the prior year, the company posted $0.25 EPS. Cognex’s revenue was up 16.9% compared to the same quarter last year. Cognex has set its FY 2026 guidance at 1.640-1.680 EPS and its Q3 2026 guidance at 0.500-0.540 EPS. Equities analysts predict that Cognex will post 1.68 EPS for the current year.

Cognex Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Thursday, September 3rd. Stockholders of record on Thursday, August 20th were given a $0.085 dividend. This represents a $0.34 dividend on an annualized basis and a dividend yield of 0.5%. The ex-dividend date was Thursday, August 20th. Cognex’s dividend payout ratio (DPR) is 33.01%.

Institutional Trading of Cognex

Several institutional investors and hedge funds have recently bought and sold shares of CGNX. BlackRock Inc. bought a new position in Cognex in the 2nd quarter worth about $1,158,123,000. California State Teachers Retirement System boosted its position in shares of Cognex by 7,134.0% during the 2nd quarter. California State Teachers Retirement System now owns 14,032,461 shares of the scientific and technical instruments company’s stock valued at $1,016,231,000 after acquiring an additional 13,838,483 shares during the last quarter. Northwestern Mutual Wealth Management Co. boosted its position in shares of Cognex by 173,138.2% during the 4th quarter. Northwestern Mutual Wealth Management Co. now owns 10,477,448 shares of the scientific and technical instruments company’s stock valued at $376,979,000 after acquiring an additional 10,471,400 shares during the last quarter. Price T Rowe Associates Inc. MD grew its holdings in shares of Cognex by 31.0% during the fourth quarter. Price T Rowe Associates Inc. MD now owns 5,314,896 shares of the scientific and technical instruments company’s stock worth $191,231,000 after purchasing an additional 1,258,629 shares in the last quarter. Finally, Disciplined Growth Investors Inc. MN grew its holdings in shares of Cognex by 0.9% during the second quarter. Disciplined Growth Investors Inc. MN now owns 4,768,716 shares of the scientific and technical instruments company’s stock worth $151,264,000 after purchasing an additional 40,927 shares in the last quarter. 88.12% of the stock is currently owned by hedge funds and other institutional investors.

Cognex Company Profile

(Get Free Report)

Cognex Corporation is a leading provider of machine vision systems, software, sensors and industrial barcode readers used to automate manufacturing, logistics and distribution processes. The company designs and develops vision-based products that help manufacturers and logistics operators inspect, identify and guide parts, assemblies and packaged goods in real time. Its solutions are applied in a broad range of industries, including automotive, electronics, semiconductor, pharmaceutical, food and beverage, and general manufacturing.

The company’s product portfolio includes stand-alone vision systems, vision sensors and deep learning-based software platforms that enable automated inspection, quality control and traceability.